6519 related articles for article (PubMed ID: 19110742)
1. Videodermatoscopy of lentigo maligna treated with imiquimod.
Micali G; Lacarrubba F; Nardone B; Nasca MR
J Drugs Dermatol; 2008 Nov; 7(11):1077-80. PubMed ID: 19110742
[TBL] [Abstract][Full Text] [Related]
2. Treatment of lentigo maligna with imiquimod 5% cream.
Hopson B; Richey D; Sajben FP
J Drugs Dermatol; 2007 Oct; 6(10):1037-40. PubMed ID: 17966182
[TBL] [Abstract][Full Text] [Related]
3. Treatment of lentigo maligna (melanoma in situ) with the immune response modifier imiquimod.
Wolf IH; Cerroni L; Kodama K; Kerl H
Arch Dermatol; 2005 Apr; 141(4):510-4. PubMed ID: 15837872
[TBL] [Abstract][Full Text] [Related]
4. [Imiquimod treatment of lentigo maligna to dermoscopic and histologic clearance].
Lorentzen HF; Weismann K
Ugeskr Laeger; 2005 Sep; 167(39):3696-7. PubMed ID: 16219219
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of dermoscopy to monitor clinical efficacy of imiquimod treatment for lentigo maligna.
Micantonio T; Fargnoli MC; Peris K
Arch Dermatol; 2006 Apr; 142(4):530-1. PubMed ID: 16618884
[No Abstract] [Full Text] [Related]
6. Lentigo maligna treated with topical imiquimod: dermatoscopy usefulness in clinical monitoring.
Costa MC; Abraham LS; Barcaui C
An Bras Dermatol; 2011; 86(4):792-4. PubMed ID: 21987152
[TBL] [Abstract][Full Text] [Related]
7. Imiquimod 5% cream as primary or adjuvant therapy for melanoma in situ, lentigo maligna type.
Swetter SM; Chen FW; Kim DD; Egbert BM
J Am Acad Dermatol; 2015 Jun; 72(6):1047-53. PubMed ID: 25791801
[TBL] [Abstract][Full Text] [Related]
8. Imiquimod in the treatment of extensive recurrent lentigo maligna.
Kamin A; Eigentler TK; Radny P; Bauer J; Weide B; Garbe C
J Am Acad Dermatol; 2005 Feb; 52(2 Suppl 1):51-2. PubMed ID: 15692515
[TBL] [Abstract][Full Text] [Related]
9. Topical 5% imiquimod in the treatment of lentigo maligna.
Wong JG; Toole JW; Demers AA; Musto G; Wiseman MC
J Cutan Med Surg; 2012; 16(4):245-9. PubMed ID: 22784516
[TBL] [Abstract][Full Text] [Related]
10. A systematic review on the role of imiquimod in lentigo maligna and lentigo maligna melanoma: need for standardization of treatment schedule and outcome measures.
Tio D; van der Woude J; Prinsen CAC; Jansma EP; Hoekzema R; van Montfrans C
J Eur Acad Dermatol Venereol; 2017 Apr; 31(4):616-624. PubMed ID: 27987308
[TBL] [Abstract][Full Text] [Related]
11. Imiquimod and lentigo maligna: a search for prognostic features in a clinicopathological study with long-term follow-up.
Powell AM; Robson AM; Russell-Jones R; Barlow RJ
Br J Dermatol; 2009 May; 160(5):994-8. PubMed ID: 19222462
[TBL] [Abstract][Full Text] [Related]
12. Lentigo maligna managed with topical imiquimod and dermoscopy: report of two cases.
de Troya-Martín M; Frieyro-Elicegui M; Fúnez Liébana R; Aguilar Bernier M; Fernández-Canedo NI; Blázquez Sánchez N
Dermatol Surg; 2008 Nov; 34(11):1561-6. PubMed ID: 18798748
[No Abstract] [Full Text] [Related]
13. Characterization of the cellular infiltrate during successful topical treatment of lentigo maligna with imiquimod.
Michalopoulos P; Yawalkar N; Brönnimann M; Kappeler A; Braathen LR
Br J Dermatol; 2004 Oct; 151(4):903-6. PubMed ID: 15491436
[TBL] [Abstract][Full Text] [Related]
14. Imiquimod treatment of lentigo maligna: an open-label study of 34 primary lesions in 32 patients.
Buettiker UV; Yawalkar NY; Braathen LR; Hunger RE
Arch Dermatol; 2008 Jul; 144(7):943-5. PubMed ID: 18645150
[No Abstract] [Full Text] [Related]
15. A pilot study of treatment of lentigo maligna with 5% imiquimod cream.
Fleming CJ; Bryden AM; Evans A; Dawe RS; Ibbotson SH
Br J Dermatol; 2004 Aug; 151(2):485-8. PubMed ID: 15327559
[TBL] [Abstract][Full Text] [Related]
16. Recurrence of lentigo maligna after initial complete response to treatment with 5% imiquimod cream.
van Meurs T; van Doorn R; Kirtschig G
Dermatol Surg; 2007 May; 33(5):623-6; discussion 626-7. PubMed ID: 17451589
[No Abstract] [Full Text] [Related]
17. [Topical imiquimod as palliative therapy for extensive lentigo maligna on the cheek].
Cheikhrouhou H; Pouaha J; Claeys A; Truchetet F
Ann Dermatol Venereol; 2010 Feb; 137(2):142-4. PubMed ID: 20171439
[No Abstract] [Full Text] [Related]
18. Topical imiquimod treatment of lentigo maligna: clinical and histologic evaluation.
Kupfer-Bessaguet I; Guillet G; Misery L; Carre JL; Leroy JP; Sassolas B
J Am Acad Dermatol; 2004 Oct; 51(4):635-9. PubMed ID: 15389205
[TBL] [Abstract][Full Text] [Related]
19. [How I treat ... lentigo maligna by topical imiquimod].
Bourguignon R; Paquet P; Quatresooz P; Piérard GE
Rev Med Liege; 2005 Sep; 60(9):691-4. PubMed ID: 16265961
[TBL] [Abstract][Full Text] [Related]
20. Treatment of lentigo maligna with imiquimod before staged excision.
Cotter MA; McKenna JK; Bowen GM
Dermatol Surg; 2008 Feb; 34(2):147-51. PubMed ID: 18093206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]